Miller Steve Insider Trades

Insider Trading History

Track insider trading activity for Miller Steve. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $34.2M 1,093,803 shares
Last Trade
Dec 29, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$337k 14,000 shares
$24.06
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $46M 1,471,649 shares
Last Trade
Dec 29, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$337k 14,000 shares
$24.06
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $33.8M 1,079,803 shares
Last Trade
Dec 08, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$279k 11,873 shares
$23.53
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $46.5M 1,485,649 shares
Last Trade
Dec 08, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$279k 11,873 shares
$23.53
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $33.4M 1,067,930 shares
Last Trade
Nov 21, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$192k 8,267 shares
$23.28
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $46.9M 1,497,522 shares
Last Trade
Nov 21, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$192k 8,267 shares
$23.28
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $46.6M 1,489,255 shares
Last Trade
Nov 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.7M 206,280 shares
$22.77
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $40.7M 1,299,509 shares
Last Trade
Aug 27, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.22M 110,000 shares
$20.19
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $33.2M 1,059,663 shares
Last Trade
Aug 27, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.22M 110,000 shares
$20.19
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $33.3M 1,064,663 shares
Last Trade
Aug 26, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.29M 115,000 shares
$19.94
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $44.1M 1,409,509 shares
Last Trade
Aug 26, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.29M 115,000 shares
$19.94
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $29.7M 949,663 shares
Last Trade
Aug 26, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.33M 115,000 shares
$20.28
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $29.7M 949,663 shares
Last Trade
Feb 14, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$318k 13,667 shares
$23.27
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $47.7M 1,524,509 shares
Last Trade
Feb 14, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$318k 13,667 shares
$23.27
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $29.3M 935,996 shares
Last Trade
Dec 27, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$301k 14,000 shares
$21.47
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $48.1M 1,538,176 shares
Last Trade
Dec 27, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$301k 14,000 shares
$21.47
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $28.8M 921,996 shares
Last Trade
Dec 13, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.02M 235,000 shares
$21.38
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $48.6M 1,552,176 shares
Last Trade
Dec 13, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.02M 235,000 shares
$21.38
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $23.1M 736,996 shares
Last Trade
Dec 10, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.11M 50,000 shares
$22.11
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Op. & Scientific Officer
Holding Value $55.9M 1,787,176 shares
Last Trade
Dec 10, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.11M 50,000 shares
$22.11
$31.29

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up